The instance of type-2 diabetes is rising around the world and creating medical complications for millions of people, but it may soon be possible to reverse the effects of the disease. Harith Rajagopalan, Co-Founder & CEO of Fractyl Laboratories discusses with Anthony Lacavera the innovative treatment the startup is working on that could halt the onset of diabetes at its source.
